Compare ALLR & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLR | LOCL |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.3M | 21.9M |
| IPO Year | 2021 | 2021 |
| Metric | ALLR | LOCL |
|---|---|---|
| Price | $0.79 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 136.5K | 15.3K |
| Earning Date | 11-13-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 60.33 |
| EPS | ★ N/A | N/A |
| Revenue | $320,000.00 | ★ $48,365,000.00 |
| Revenue This Year | N/A | $93.32 |
| Revenue Next Year | N/A | $25.13 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.82 |
| 52 Week Low | $0.77 | $0.60 |
| 52 Week High | $1.84 | $3.13 |
| Indicator | ALLR | LOCL |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 32.32 |
| Support Level | N/A | $0.60 |
| Resistance Level | $1.45 | $1.23 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 3.70 | 26.56 |
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.
Local Bounti Corp is a controlled environment agriculture company. The business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides. The products of the company include living lettuce, leafy greens, herbs, and others.